by Thomas Rønn | Nov 5, 2021 | Press Releases, Uncategorised
Congratulations to our portfolio company IO Biotech on the successful IPO on NASDAQ. Great achievement for this pioneering company, and a milestone in the development of new pioneering treatments for Cancer patients based on the company’s T-win technology. Read the...
Recent Comments